Does APIXABAN Cause Haemoptysis? 846 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 846 reports of Haemoptysis have been filed in association with APIXABAN (ELIQUIS). This represents 0.5% of all adverse event reports for APIXABAN.
846
Reports of Haemoptysis with APIXABAN
0.5%
of all APIXABAN reports
129
Deaths
497
Hospitalizations
How Dangerous Is Haemoptysis From APIXABAN?
Of the 846 reports, 129 (15.2%) resulted in death, 497 (58.7%) required hospitalization, and 217 (25.7%) were considered life-threatening.
Is Haemoptysis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for APIXABAN. However, 846 reports have been filed with the FAERS database.
What Other Side Effects Does APIXABAN Cause?
Death (18,501)
Cerebrovascular accident (7,237)
Atrial fibrillation (5,690)
Off label use (5,590)
Thrombosis (5,298)
Fall (5,063)
Cardiac disorder (4,917)
Haemorrhage (4,770)
Dyspnoea (4,379)
Gastrointestinal haemorrhage (4,030)
What Other Drugs Cause Haemoptysis?
RIVAROXABAN (1,961)
ASPIRIN (1,255)
TREPROSTINIL (838)
ALBUTEROL (652)
CLOPIDOGREL BISULFATE (643)
PREDNISONE (618)
WARFARIN (555)
ADALIMUMAB (472)
TIOTROPIUM (462)
MEPOLIZUMAB (449)
Which APIXABAN Alternatives Have Lower Haemoptysis Risk?
APIXABAN vs APOMORPHINE
APIXABAN vs APRACLONIDINE
APIXABAN vs APREMILAST
APIXABAN vs APREPITANT
APIXABAN vs APROTININ